News for 'drug control'

WHO wrong in linking Gambia kids deaths to Indian cough syrups: DCGI

WHO wrong in linking Gambia kids deaths to Indian cough syrups: DCGI

Rediff.com16 Dec 2022

In the letter, Somani said the samples of four made-in-India cough syrups linked to the deaths of 66 children in Gambia which were tested in government laboratory here were found to be complying with specifications and not to have been contaminated with DEG or EG according to the test reports.

Cruise drug case: Bizman moves HC over media campaign

Cruise drug case: Bizman moves HC over media campaign

Rediff.com6 Oct 2021

The Delhi High Court Wednesday asked a news company to "hold its hand" for the time being and not publish any information against a Delhi-based businessman in connection with a drugs case involving the son of a Bollywood actor.

Safe birth control 'pill' for men a step closer

Safe birth control 'pill' for men a step closer

Rediff.com13 Apr 2016

The newly discovered enzyme decreases the sperm's ability to swim, so that fertilisation cannot occur.

Must Watch: Stories From Around The World

Must Watch: Stories From Around The World

Rediff.com1 Oct 2024

Aseem Chhabra's Top 10 Films/ Series from TIFF 2024 includes films that he watched for the first time in Toronto. The films were impressive due to their rigor, passion, unique storytelling style and sometimes exploring the vulnerable sides of big name stars.

Health min recommends anti-malarial drug for COVID-19

Health min recommends anti-malarial drug for COVID-19

Rediff.com31 Mar 2020

The ministry has removed its earlier recommendation of the use of anti-HIV drug combinations Lopinavir and Ritonavir on a case-to-case basis depending upon the severity of the condition of a patient suffering from coronavirus infection.

Govt panel seeks additional data from SII on Covovax

Govt panel seeks additional data from SII on Covovax

Rediff.com28 Nov 2021

The Serum Institute of India (SII) had put in an application to the Drugs Controller General of India (DCGI) in October for grant of market authorisation of Covovax for restricted use in emergency situations.

Trade margins capped at 70% for oximeters, BP meters, other medical devices

Trade margins capped at 70% for oximeters, BP meters, other medical devices

Rediff.com14 Jul 2021

The medical devices, which have been in high demand during the Covid-19 pandemic, will now see a drop in prices, as the earlier margins were up to 709 per cent for some of these products.

'Big Boost': Bharat Biotech's nasal vaccine against Covid cleared for use

'Big Boost': Bharat Biotech's nasal vaccine against Covid cleared for use

Rediff.com6 Sep 2022

The Hyderabad-based firm completed clinical trials of the nasal vaccine with about 4,000 volunteers and there is no side effect or adverse reaction reported so far, company sources had said.

Current epidemic law can't handle future crisis, needs overhaul, says panel

Current epidemic law can't handle future crisis, needs overhaul, says panel

Rediff.com13 Feb 2024

The panel headed by Justice (retired) Ritu Raj Awasthi has submitted its report to the government, calling for an exhaustive overhaul of the law.

6 major companies found manufacturing 'substandard' drugs

6 major companies found manufacturing 'substandard' drugs

Rediff.com18 May 2016

Alkem Labs was issued drug alerts twice last year -- in June and July -- for its drug Glimekem.

As drug firms squirm, authorities look abroad for cure

As drug firms squirm, authorities look abroad for cure

Rediff.com23 Sep 2013

DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices

Punjab recommends death penalty for drug smuggling

Punjab recommends death penalty for drug smuggling

Rediff.com2 Jul 2018

The recommendation is being forwarded to the Union government.

Advertisers feel the heat of Bollywood drug abuse probe

Advertisers feel the heat of Bollywood drug abuse probe

Rediff.com1 Oct 2020

Advertising agencies admitted that conversations had begun with their clients to exercise restraint while using brand endorsements featuring film actors whose names appeared in the probe.

Sun Pharma's growth pill: Specialising in specialty and scaling in India

Sun Pharma's growth pill: Specialising in specialty and scaling in India

Rediff.com25 Mar 2024

Traction for its specialty portfolio, a strong showing in the domestic market, and better regulatory compliance are positives for the country's largest pharmaceutical (pharma) company, Sun Pharmaceutical Industries. Given the triggers, some brokerages have increased their earnings per share estimates and target price for 2024-25 (FY25). This should sustain the momentum for the stock, which has been one of the major pharma gainers in 2023-24 (FY24), rising 57 per cent. It is currently trading at Rs 1,547 per share.

Drugs case: SC asks police to not arrest Majithia till Feb 23

Drugs case: SC asks police to not arrest Majithia till Feb 23

Rediff.com31 Jan 2022

In a relief toD leader Bikram Singh Majithia, the Supreme Court Monday directed the Punjab police not to arrest him till February 23 in a drugs case so he can undertake electioneering

Kangana faces 'drug link' probe; Mumbai home under BMC lens

Kangana faces 'drug link' probe; Mumbai home under BMC lens

Rediff.com8 Sep 2020

Maharashtra Home Minister Anil Deshmukh said Adhyayan, the son of actor Shekhar Suman, was once in a relationship with Ranaut and he had alleged that she used to take drugs.

How Modi-Shah Defeated The Stone-Pelters In Kashmir

How Modi-Shah Defeated The Stone-Pelters In Kashmir

Rediff.com10 May 2024

'An entire operation was running systematically prior to the revoking of Article 370.'

Serum Institute gets nod to resume vaccine trial in India

Serum Institute gets nod to resume vaccine trial in India

Rediff.com16 Sep 2020

SII has been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events.

NDA more eager to cap drug prices than UPA

NDA more eager to cap drug prices than UPA

Rediff.com14 Jan 2016

The impact from NELM on the Indian pharmaceutical sector is estimated to be around Rs 6,000 crore.

DCGI orders Serum to suspend recruitment for COVID-19 vaccine trials

DCGI orders Serum to suspend recruitment for COVID-19 vaccine trials

Rediff.com11 Sep 2020

The DCGI also directed Serum Institute of India to increase the safety monitoring of the subjects already vaccinated as part of the trial, and submit the plan and report.

Anti-cancer drugs to be cheaper soon

Anti-cancer drugs to be cheaper soon

Rediff.com18 Jun 2013

The drug pricing regulator on Tuesday said it will fix the ceiling prices of over 300 medicines by the end of this month, a move that will come as a major relief to patients.

Doval moots interoperability among central police forces

Doval moots interoperability among central police forces

Rediff.com24 May 2024

National security advisor Ajit Doval on Friday suggested that various central armed police forces of the country should have "jointness" and interoperability among themselves like the ongoing plan for the defence forces.

Crocin Quick gives GSK a headache

Crocin Quick gives GSK a headache

Rediff.com27 Sep 2005

Lupin recalls 5.61 lakh pouches of India-made birth control pills in US

Lupin recalls 5.61 lakh pouches of India-made birth control pills in US

Rediff.com21 Aug 2020

Baltimore-based Lupin Pharmaceuticals Inc is recalling 5,60,922 pouches of Mibelas 24 Fe (norethindrone acetate and Ethinyl estradiol tablets and ferrous fumarate tablets) in the US, as per the latest enforcement report by the USFDA.

Corbevax cleared for kids in 5-12 yrs age group, Covaxin for 6-12

Corbevax cleared for kids in 5-12 yrs age group, Covaxin for 6-12

Rediff.com26 Apr 2022

The approval by the Drugs Controller General of India comes following recommendations by the Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation.

Regulator finds Alkem Labs drug substandard, again

Regulator finds Alkem Labs drug substandard, again

Rediff.com9 Jun 2016

The regulator had issued alerts in June and July of 2015.

HC seeks status report from govt on illegal sale of medicines online

HC seeks status report from govt on illegal sale of medicines online

Rediff.com15 Mar 2023

The petitioner's lawyer interjected the rules are being framed for the last 5-6 years but nothing concrete has been done yet.

Drug regulator lets pharma firms fix own penalty

Drug regulator lets pharma firms fix own penalty

Rediff.com20 Jan 2014

Even as the Supreme Court had recently dismissed the industry's plea against prices fixed by the regulator and its timely implementation, the National Pharmaceutical Pricing Authority has asked companies to pay the overcharged dues with 15 per cent interest.

Price curbs on AIDS drugs

Price curbs on AIDS drugs

Rediff.com25 Dec 2004

'Decisive turning point': PM hails approval to vaccines

'Decisive turning point': PM hails approval to vaccines

Rediff.com3 Jan 2021

In a series of tweets after the Drugs Controller General of India (DCGI) approved Oxford's vaccine Covishield and Bharat Biotech's Covaxin for restricted emergency use, Modi said it will make every Indian proud that both the vaccines are made in India.

Criminal complaint against Ramdev for COVID-19 drug claim

Criminal complaint against Ramdev for COVID-19 drug claim

Rediff.com24 Jun 2020

The complaint seeking registration of a first information report on cheating, criminal conspiracy and other charges was filed in the court of Chief Judicial Magistrate Mukesh Kumar here on Tuesday by Tamanna Hashmi, who identifies himself as a social worker and is often in news for his numerous court complaints against politicians over various issues.

Huge growth in clinical trials in India

Huge growth in clinical trials in India

Rediff.com24 Nov 2008

Clinical trials in the country have witnessed a tremendous growth in recent years, a top government official said.

Luxury car mows down 2 in Pune; teen driver's father, bar to be booked

Luxury car mows down 2 in Pune; teen driver's father, bar to be booked

Rediff.com19 May 2024

The 17-year-old car driver was detained after a case was registered against him. He was produced in a juvenile court which granted him bail, they said.

DGCI approves Covaxin for phase 2/3 trials on children

DGCI approves Covaxin for phase 2/3 trials on children

Rediff.com13 May 2021

India's apex drug regulator has granted permission for conducting the phase II/III clinical trial of Bharat Biotech's Covaxin COVID-19 vaccine in the age group of 2 to 18 years, the Union Health Ministry said on Thursday.

Serum seeks emergency use for its COVID-19 vaccine

Serum seeks emergency use for its COVID-19 vaccine

Rediff.com7 Dec 2020

SII is the first indigenous company that has sought emergency approval for the vaccine developed along with global pharma giant AstraZeneca and Oxford University.

Serum Inst gets DGCI notice over continuation of vaccine trial

Serum Inst gets DGCI notice over continuation of vaccine trial

Rediff.com9 Sep 2020

The show-cause notice was issued following reports that human trials of the most promising COVID-19 vaccine candidate, being developed by the University of Oxford, have been put on hold after a United Kingdom participant had an adverse reaction to it.

Mirzapur 3 Review: Too Much Gore

Mirzapur 3 Review: Too Much Gore

Rediff.com5 Jul 2024

Pankaj Tripathi anchored the first two seasons with his performance. Here, he is made to sit it out for most of the show, and none of the actors, except for a fiery Ali Fazal, have the charisma to hold the viewer's attention, observes Deepa Gahlot.

Sushant case: Look out circulars against Rhea quashed

Sushant case: Look out circulars against Rhea quashed

Rediff.com22 Feb 2024

The Bombay high court on Thursday quashed the Look Out Circulars (LOCs) issued against Rhea Chakraborty, her brother and father by the Central Bureau of Investigation (CBI) in connection with its probe into the death of actor Sushant Singh Rajput.

WHO suspends Covaxin supply to UN agencies

WHO suspends Covaxin supply to UN agencies

Rediff.com3 Apr 2022

A statement issued by the WHO on Saturday said the suspension is in response to the outcomes of its post EUL (emergency use authorisation) inspection held between March 14-22, 2022 and the need to conduct process and facility upgrade to address recently identified GMP (good manufacturing practice) deficiencies.

Medic's murder: IMA survey reveals 35% of doctors feel unsafe

Medic's murder: IMA survey reveals 35% of doctors feel unsafe

Rediff.com30 Aug 2024

The respondents were from over 22 states with 85 percent of them being under 35 years while 61 percent were interns or postgraduate trainees.